137 related articles for article (PubMed ID: 32552139)
41. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
42. COVID-19: beta-thalassemia subjects immunised?
Lansiaux E; Pébaÿ PP; Picard JL; Son-Forget J
Med Hypotheses; 2020 Sep; 142():109827. PubMed ID: 32447232
[TBL] [Abstract][Full Text] [Related]
43. Neither ACEIs nor ARBs are associated with respiratory distress or mortality in COVID-19 results of a prospective study on a hospital-based cohort.
Anzola GP; Bartolaminelli C; Gregorini GA; Coazzoli C; Gatti F; Mora A; Charalampakis D; Palmigiano A; De Simone M; Comini A; Dellaglio E; Cassetti S; Chiesa M; Spedini F; d'Ottavi P; Savio MC
Intern Emerg Med; 2020 Nov; 15(8):1477-1484. PubMed ID: 32965603
[TBL] [Abstract][Full Text] [Related]
44. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
45. The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
Uvais NA
Prim Care Companion CNS Disord; 2020 Apr; 22(3):. PubMed ID: 32369686
[No Abstract] [Full Text] [Related]
46. SARS-CoV-2 Infection in a 2-Week-Old Male With Neutropenia.
Patek P; Corcoran J; Adams L; Khandhar P
Clin Pediatr (Phila); 2020 Sep; 59(9-10):918-920. PubMed ID: 32292054
[No Abstract] [Full Text] [Related]
47. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
48. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China.
Ran J; Song Y; Zhuang Z; Han L; Zhao S; Cao P; Geng Y; Xu L; Qin J; He D; Wu F; Yang L
Hypertens Res; 2020 Nov; 43(11):1267-1276. PubMed ID: 32855527
[TBL] [Abstract][Full Text] [Related]
49. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
[TBL] [Abstract][Full Text] [Related]
50. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction.
Akşit E; Kırılmaz B; Gazi E; Aydın F
Balkan Med J; 2020 Jun; 37(4):233-233. PubMed ID: 32326691
[No Abstract] [Full Text] [Related]
51. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
52. Management of COVID-19 in people with epilepsy: drug considerations.
Asadi-Pooya AA; Attar A; Moghadami M; Karimzadeh I
Neurol Sci; 2020 Aug; 41(8):2005-2011. PubMed ID: 32594268
[TBL] [Abstract][Full Text] [Related]
53. Rare Anaemias, Sickle-Cell Disease and COVID-19.
Vives Corrons JL; De Sanctis V
Acta Biomed; 2020 May; 91(2):216-217. PubMed ID: 32420949
[TBL] [Abstract][Full Text] [Related]
54. Different outcome of COVID-19 in members of a family.
Sun J; Jiang Y; Lin W; Hu WH; Wang Y
J Infect Dev Ctries; 2020 May; 14(5):447-449. PubMed ID: 32525829
[TBL] [Abstract][Full Text] [Related]
55. Arterial hypertension and COVID-19 infections: A brief commentary.
Widimský J
Vnitr Lek; 2020; 66(3):104-106. PubMed ID: 32972176
[TBL] [Abstract][Full Text] [Related]
56. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.
Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW
J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607
[TBL] [Abstract][Full Text] [Related]
57. Facts and reflections on COVID-19 and anti-hypertensives drugs.
Marin GH
Drug Discov Ther; 2020 May; 14(2):105-106. PubMed ID: 32213760
[TBL] [Abstract][Full Text] [Related]
58. Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.
Surma S; Romańczyk M; Łabuzek K
Pol Merkur Lekarski; 2020 Jun; 48(285):195-198. PubMed ID: 32564046
[TBL] [Abstract][Full Text] [Related]
59. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.
Iaccarino G; Borghi C; Cicero AFG; Ferri C; Minuz P; Muiesan ML; Mulatero P; Mulè G; Pucci G; Salvetti M; Savoia C; Sechi LA; Volpe M; Grassi G
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):105-108. PubMed ID: 32266708
[TBL] [Abstract][Full Text] [Related]
60. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).
Gupta R; Misra A
Diabetes Metab Syndr; 2020; 14(3):251-254. PubMed ID: 32247213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
